world-biochem-regenerative-medicine-2019-keynote

9 / 11

World Biochem 2019 & Regenerative Medicine 2019 Journal of Genetics and Molecular Biology | Volume 3
Page 37
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
March 25-26, 2019 | Amsterdam, Netherlands
&
BIOCHEMISTRY AND ENZYMOLOGY
World Congress on
TISSUE ENGINEERING AND REGENERATIVE MEDICINE, STEM CELL RESEARCH
2nd Global Conference on
Joint Event on
REGENERATIVE MEDICINE IN
NONSURGICAL ORTHOPAEDICS &
SPORTS MEDICINE
The number of sports injuries and orthopedic conditions, such as Osteoarthri-
tis of the knee, in the population is considerable. Time loss can vary from a
few days to end-of-season or beyond. In addition, many of these conditions
represent a significant cost in lost time from work and lost wages. When injured,
many musculoskeletal structures do not completely regain their normal structur-
al and biomechanical properties, resulting in the formation of scar tissue, which
increase the risk of re-injury. This is due to poor vascularization which reduces the
availability of oxygen, growth factors and other nutrients necessary for tissue re-
generation which significantly affects the quality and speed of healing response.
However, healing may potentially be enhanced and expedited by new non-sur-
gical regenerative medicine treatments using a patient’s own growth factors to
promote healing. Regenerative medicine is of particular interest as evidence in-
creasingly refute the commonly used patient pathway of rest, anti-inflammatory
medications, corticosteroid injections and surgery. There is mounting evidence
to suggest that treatments such as platelet rich Plasma (PRP), Lipogems, Alpha
2 Macroglobulin (A2M) and Extracorporeal Shockwave therapy (ESWT) may pro-
vide an adjuvant or alternative treatment option for conditions that affect muscle,
tendons, ligaments, and cartilage.These techniques are also appealing to patients
as they are minimally invasive and are often performed in a relaxed out- patient
setting, with little down time. Another major advantage of regenerative medicine
is that patients use“their own body tissue”for natural healing process.These treat-
ments are easy to prepare, administer, safe, effective, available immediately at the
point of care; and cost- effectiveness comparedwith surgical options.The promise
of regenerative medicine in non- surgical orthopedics and sports injuries is excit-
ing and may prove to be“Game Changer”!
Ralph Rogers, J Genet Mol Biol 2019, Volume 3
Ralph Rogers is a consultant in regenera-
tive orthopaedics & sports medicine. He
studied medicine at the University of Leu-
ven (Belgium) and after completion of PhD
in Exercise Physiology at the University of
Maryland (USA). He was also a research fel-
low at the National Institute of Health (NIH).
Rogers continued his educational pursuit
by receiving an MBA from the University of
Leicester. He travels extensively to the USA
and europe to explore various regenerative
Medical techniques and was among the first
Physicians in the UK to implement Regenera-
tive orthopaedics in his clinical practice. He is
the founder of the Rogers Regenerative Me-
dial Group where the goal is to treat patients
and share best practice in the cutting-edge
field of regenerative medicine therapies with
physicians around the world.
Ralph Rogers
Rogers Regenerative Medical Group, UK
BIOGRAPHY